REDD-1 siRNA (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemREDD-1 siRNA (h)
CompanySanta Cruz Biotechnology, Inc.
Price $293.00Supplier Page View Company Product Page
Catalog Numbersc-45806
Gene NameDNA-damage-inducible transcript 4
Quantity10 µM
Specieshuman
NCBI Full Gene NameDNA damage inducible transcript 4
NCBI Gene AliasesDig2, REDD-1, REDD1
TypesiRNA/dsRNA

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) The REDD1–NF-κB–miRNAs–eNOS/SIRT1 axis mediates obesity-induced endothelial cell senescence and hypertensionNature CommunicationsMarch 12, 2026Yoon Kyung Choi, Dong-Keon Lee, Minsik Park, Junyoung Byeon, Woo-Young Nam, Thuy Linh Lai, Kyu Nam Kim, Okhwa Kim, Sungwoo Ryoo, Jeong-Hyung Lee, et al.between passages 4 and 5 were transfected with siRNAs (80 nM, control siRNA, #sc-37007; human REDD1, #sc-45806; mouse Redd1, #sc-45807; human IKKβ, #sc-35644; human NF-κB p65, #sc-29410; mouse NF-κB p65, #sc-29411;

(2) Accelerated cartilage regeneration via chondrocyte metabolic reprogramming using nano-steroid-conjugated mesenchymal stem cells in osteoarthritisTheranosticsJanuary 1, 2026Jong Yeong Lee, Jun Young Park, In Ah Kwon, Su Hyun Lim, Ki Bum Kim, Jun-Young Park, Youn Joo Kang, Sang-Hyun Kim, Dongwoo Khang, Jin Kyeong Choilisted in Table S3. siRNA transfection Chondrocytes were transfected with siRNAs targeting DDIT4 (sc-45806; Santa Cruz Biotechnology) or AMPKα1/2 (sc-45312; Santa Cruz Biotechnology), along with a non-targeting

(3) Advanced single-cell pooled CRISPR screening identifies C19orf53 required for cell proliferation based on mTORC1 regulatorsCell biology and toxicologyFebruary 1, 2022Tang Y, Liao S, Liu G, Xiong X, Liu H, Li F, Tan Z, Kong X, Yin Y, Tan B.

(4) Amino acid deprivation induces AKT activation by inducing GCN2/ATF4/REDD1 axisCell death & diseaseDecember 3, 2021Jin HO, Hong SE, Kim JY, Jang SK, Park IC.(pEF/mATF4-myc) was kindly provided by Dr. Jawed Alam [30]. GCN2 (#sc-45644), ATF4 (#sc-35112), REDD1 (#sc-45806), Rictor (#sc-61478), Sin1 (#sc-60984) and control (#sc-37007) siRNAs were purchased from Santa Cruz Biotechnology

(5) REDD1 is a determinant of low-dose metronomic doxorubicin-elicited endothelial cell dysfunction through downregulation of VEGFR-2/3 expressionExperimental & molecular medicineOctober 1, 2021Park M, Kim J, Kim T, Kim S, Park W, Ha KS, Cho SH, Won MH, Lee JH, Kwon YG, et al.or transfected with 80 nM small interfering RNA (siRNA), either the control (#SC-37007) or Redd1 (#SC-45806; Santa Cruz Biotechnology, Dallas, TX), using Lipofectamine RNAiMAX (Invitrogen, Carlsbad, CA) according

(6) Inhibition of mTORC1 through ATF4-induced REDD1 and Sestrin2 expression by MetforminBMC cancerJuly 12, 2021Jang SK, Hong SE, Lee DH, Kim JY, Kim JY, Ye SK, Hong J, Park IC, Jin HO.

(7) Induction of HSP27 and HSP70 by constitutive overexpression of Redd1 confers resistance of lung cancer cells to ionizing radiationOncology reportsMay 1, 2019Jin HO, Hong SE, Kim JY, Kim MR, Chang YH, Hong YJ, Lee JK, Park IC.stage II, 10 stage III, and 2 stage IV lung cancer samples. siRNAs and transfections. Redd1 (cat. no. sc‑45806), AKT1/2 (cat. no. sc‑43609), Rictor (cat. no. sc‑61478) and control (cat. no. sc‑37007) siRNAs were

(8) Melatonin enhances arsenic trioxide-induced cell death via sustained upregulation of Redd1 expression in breast cancer cellsMolecular and cellular endocrinologyFebruary 15, 2016Yun SM, Woo SH, Oh ST, Hong SE, Choe TB, Ye SK, Kim EK, Seong MK, Kim HA, Noh WC, et al.

(9) ATF4 Gene Network Mediates Cellular Response to the Anticancer PAD Inhibitor YW3-56 in Triple-Negative Breast Cancer CellsMolecular cancer therapeuticsApril 1, 2015Wang S, Chen XA, Hu J, Jiang JK, Li Y, Chan-Salis KY, Gu Y, Chen G, Thomas C, Pugh BF, et al.control scrambled siRNA, ATF4 siRNA, SESN2 siRNA (Santa cruz, sc-106544), and DDIT4 siRNA (Santa cruz, sc-45806) were transfected into 1833 cells. At 24 hr following transfection, YW3-56 was added to treat the cells

(10) Sustained overexpression of Redd1 leads to Akt activation involved in cell survivalCancer lettersAugust 19, 2013Jin HO, Hong SE, Kim JH, Choi HN, Kim K, An S, Choe TB, Hwang CS, Lee JH, Kim JI, et al.

Be the First to Write a Review!

REDD-1 siRNA (h)

REDD-1 siRNA (h) from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (10)

Reviews

REDD-1 siRNA (h) from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map